Updacitinib- (Rinvoq) - (Aug-2019)- Anti-rhrumatic drug
Drug Name:
Updacitinib- (Rinvoq) - (Aug-2019)- Anti-rhrumatic drug
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2019
Sr.No.26.
Name of the Drug- Nourianz
Active Ingredient - Istradefylline
Pharmacological Classification-
To treat adult patients with Parkinsons disease experiencing
"off" episodes
Date of Approval - 8/27/2019
(Ref- FDA approved List 2019
Sr.No.23.
Name of the Drug- Rinvoq
Active Ingredient - Upadactinib
Pharmacological Classification-
To treat adult patients with moderately rheumatoid arthiritis
Date of Approval - 8/16/2019
(Ref- FDA approved List 2019